SCHEMBL7091956

SCHEMBL7091956

Cc1nc(-c2cccc(Cl)c2)c2c(-c3cncn3C)c(CO)c(-c3ccc(Cl)cc3)cc2n1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.47
FNTA P49354 10/20 0.35
FNTB P49356 10/20 0.35
RORC P51449 3/20 0.34
GSK3B P49841 1/20 0.34
DYRK1A Q13627 1/20 0.34
MAPK1 P28482 1/20 0.34
PGGT1B P53609 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BDKRB2 P30411 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7089905 0.92 IDO1 (0.47) IDO1FNTAFNTBRORCGSK3B
SCHEMBL7092101 0.90 IDO1 (0.46) IDO1FNTAFNTBRORCMAPK1
SCHEMBL7091512 0.87 IDO1 (0.43) IDO1FNTAFNTBGSK3BDYRK1A
SCHEMBL7210392 0.76 IDO1 (0.52) IDO1FNTAFNTBRORCMAPK1
SCHEMBL6556841 0.72 FNTA (0.52) IDO1FNTAFNTBMAPK1PGGT1B
SCHEMBL7094385 0.71 IDO1 (0.48) IDO1FNTAFNTBRORCGSK3B
SCHEMBL7095527 0.68 IDO1 (0.44) IDO1FNTAFNTBMAPK1PGGT1B
SCHEMBL23539669 0.67 IDO1 (1.00) IDO1FNTAFNTBGSK3BDYRK1A
SCHEMBL30042691 0.67 IDO1 (1.00) IDO1FNTAFNTBGSK3BDYRK1A
SCHEMBL28532205 0.67 IDO1 (0.50) IDO1FNTAFNTBPGGT1BCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322635-A1 FARNESYL TRANSFERASE INHIBITING QUINOLINE AND QUINAZOLINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-07-02 EP disclosed
WO-2002024682-A1 FARNESYL TRANSFERASE INHIBITING QUINOLINE AND QUINAZOLINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2002-03-28 WO disclosed